Pain management in patients with malignant mesothelioma: challenges and solutions

References

• British Thoracic Society Standards of Care CommitteeBTS statement on malignant mesothelioma in the UK, 2007Thorax200762Suppl 2ii1ii1917965072
   PubMed Web of Science ®Google Scholar
• McDonaldJCMcDonaldADThe epidemiology of mesothelioma in historical contextEur Respir J199699193219428880114
   PubMed Web of Science ®Google Scholar
• Cancer Research UK [Internet]Mesothelioma statistics Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/mesotheliomaAccessed October 8, 2018
   Google Scholar
• SalminenEKSilvoniemiMSyrjänenKKaasaSKlokeMKlepstadPOpioids in pain management of mesothelioma and lung cancer patientsActa Oncol2013521303723025295
   PubMed Web of Science ®Google Scholar
• MacleodNKellyCStoboJPain in malignant pleural mesothe-lioma: a prospective characterization studyPain Med201617112119212627117437
   PubMed Web of Science ®Google Scholar
• BaasPFennellDKerrKMMalignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and followupAnn Oncol201526Suppl5v31v3926223247
   PubMed Web of Science ®Google Scholar
• MerskeyHBNClassification of Chronic Pain2nd ed1994SeattleIASP Press1994
   Google Scholar
• WebbJALeblancTWEvidence-based management of cancer painSemin Oncol Nurs201834321522630100369
   PubMed Web of Science ®Google Scholar
• SimmonsCPLMacleodNLairdBJAClinical management of pain in advanced lung cancerClin Med Insights Oncol20126S8331S8346
   Google Scholar
• JacksonMBPounderDPriceCMatthewsAWNevilleEPercutaneous cervical cordotomy for the control of pain in patients with pleural mesotheliomaThorax199954323824110325900
   PubMed Web of Science ®Google Scholar
• VentafriddaVTamburiniMCaraceniAde ConnoFNaldiFA validation study of the WHO method for cancer pain reliefCancer19875948508563802043
   PubMed Web of Science ®Google Scholar
• LairdBColvinLFallonMManagement of cancer pain: basic principles and neuropathic cancer painEur J Cancer20084481078108218439818
   PubMed Web of Science ®Google Scholar
• Vargas-SchafferGIs the WHO analgesic ladder still valid? Twenty-four years of experienceCan Fam Physician2010566514517e202e20520547511
   PubMed Web of Science ®Google Scholar
• NHS Scotland Palliative Care Guidelines [webpage on the Internet] Available from: https://www.palliativecareguidelines.scot.nhs.uk/Accessed February 14, 2019
   Google Scholar
• ClinicalTrials.gov [Internet]University of Edinburgh. Identifier: NCT02706769. A double-blind randomised parallel group trial of paracetamol versus placebo in conjunction with strong opioids for cancer related pain Available from: https://clinicaltrials.gov/ct2/show/record/NCT02706769AccessedOctober 9, 2018
   Google Scholar
• WiffenPJWeeBDerrySBellRFMooreRAOpioids for cancer pain – an overview of Cochrane reviewsCochrane Database Syst Rev20177CD01259228683172
   PubMed Web of Science ®Google Scholar
• RipamontiCIPain managementAnn Oncol201223Suppl 10x294x30122987980
   PubMed Web of Science ®Google Scholar
• WickhamRJCancer pain management: comprehensive assessment and nonopioid analgesics, part 1J Adv Pract Oncol20178547549030079265
   PubMedGoogle Scholar
• Schmidt-HansenMBennettMIArnoldSBromhamNHilgartJSOxycodone for cancer-related painCochrane Database Syst Rev20152Cd003870
   Google Scholar
• TeohPJCammCFNICE opioids in palliative care (clinical guideline 140) – a guideline summaryAnn Med Surg201214448
   Google Scholar
• BennettMIEffectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic reviewPalliat Med201125555355920671006
   PubMed Web of Science ®Google Scholar
• StevensCWForsterKMSmytheWRRiceDRadiotherapy for meso-theliomaHematol Oncol Clin North Am200519610991115vii16325126
   PubMed Web of Science ®Google Scholar
• BoutinCReyFViallatJRPrevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapyChest199510837547587656629
   PubMed Web of Science ®Google Scholar
• BydderSPhillipsMJosephDJA randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesotheliomaBr J Cancer200491191015199394
   PubMed Web of Science ®Google Scholar
• O’RourkeNGarciaJCPaulJLawlessCMcMeneminRHillJA randomised controlled trial of intervention site radiotherapy in malignant pleural mesotheliomaRadiother Oncol2007841182217588698
   PubMed Web of Science ®Google Scholar
• BaymanNArdronDAshcroftLProtocol for pit: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall interventionBMJ Open201661e010589
   Web of Science ®Google Scholar
• CliveAOTaylorHDobsonLProphylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (smart): a multicentre, open-label, phase 3, randomised controlled trialLancet Oncol20161781094110427345639
   PubMed Web of Science ®Google Scholar
• KindlerHLIsmailaNArmatoSGTreatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guidelineJ Clin Oncol201836131343137329346042
   PubMed Web of Science ®Google Scholar
• MacleodNPriceAO’RourkeNFallonMLairdBRadiotherapy for the treatment of pain in malignant pleural mesothelioma: a systematic reviewLung Cancer201483213313824314815
   PubMed Web of Science ®Google Scholar
• MacleodNChalmersAO’RourkeNIs radiotherapy useful for treating pain in mesothelioma? A phase II trialJ Thorac Oncol201510694495025654216
   PubMed Web of Science ®Google Scholar
• AshtonMO’RourkeNMacleodNSYSTEMS-2: a randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesotheliomaClin Transl Radiat Oncol20188454929594241
   PubMed Web of Science ®Google Scholar
• ParkerCNevilleELung cancer * 8: management of malignant meso-theliomaThorax200358980981312947146
   PubMed Web of Science ®Google Scholar
• EisenbergEMFBirkhahmJPaladínAVarrassiGTime to modify the WHO analgesic leader?Pain Clin Update200513514
   Google Scholar
• Department of healthClinical programmes: Cancer. Mesothelioma framework Published 27 02 2007 . Available from: https://webarchive.nationalarchives.gov.uk/20130124034731/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_072347.pdfAccessed February 14, 2019
   Google Scholar
• FranceBDLewisRASharmaMLPoolmanMCordotomy in mesothelioma-related pain: a systematic reviewBMJ Support Palliat Care2014411929
   Google Scholar
• FallonMGiustiRAielliFManagement of cancer pain in adult patients: ESMO clinical practice guidelinesAnn Oncol201829Suppl 4iv166iv19130052758
   PubMed Web of Science ®Google Scholar
• FeizerfanAAntrobusJHLRole of percutaneous cervical cordotomy in cancer pain managementCont Educ Anaesth Crit Care Pain20141412326
   Google Scholar
• HochbergUElguetaMFPerezJInterventional analgesic management of lung cancer painFront Oncol20177121728261561
   PubMed Web of Science ®Google Scholar
• WongFCLeeTWYuenKKLoSHSzeWKTungSYIntercostal nerve blockade for cancer pain: effectiveness and selection of patientsHong Kong Med J200713426627017664531
   PubMedGoogle Scholar
• MatchettGIntercostal nerve block and Neurolysis for intractable cancer painJ Pain Palliat Care Pharmacother201630211411727092398
   PubMed Web of Science ®Google Scholar
• AhmedABhatnagarSKhuranaDJoshiSThulkarSUltrasound-guided radiofrequency treatment of intercostal nerves for the prevention of incidental pain arising due to rib metastasisAm J Hosp Palliat Care201734211512426656033
   PubMed Web of Science ®Google Scholar
• JuHFengYYangBXWangJComparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain controlEur J Pain200812337838417870625
   PubMed Web of Science ®Google Scholar
• AmbrogiVMineoDGattiAPompeoEMineoTCSymptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesotheliomaJ Surg Oncol2009100319920419274670
   PubMed Web of Science ®Google Scholar
• CaoCTianDParkJAllanJPatakyKAYanTDA systematic review and meta-analysis of surgical treatments for malignant pleural meso-theliomaLung Cancer201483224024524360321
   PubMed Web of Science ®Google Scholar
• TreasureTLang-LazdunskiLWallerDExtra-pleural pneu-monectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma and radical surgery (MARs) randomised feasibility studyLancet Oncol201112876377221723781
   PubMed Web of Science ®Google Scholar
• WederWStahelRABaasPThe Mars feasibility trial: conclusions not supported by dataLancet Oncol2011121210931094
   PubMed Web of Science ®Google Scholar
• Lang-LazdunskiLSurgery for malignant pleural mesothelioma: why, when and what?Lung Cancer201484210310924602395
   PubMed Web of Science ®Google Scholar
• FloresRMPassHISeshanVEExtrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patientsJ Thorac Cardiovasc Surg20081353620626626.e1318329481
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]Royal brompton & harefield NHS foundation trustidentifier: NCT02040272. Mesothelioma and radical surgery 2: a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma (mars 2) Available from: https://clinicaltrials.gov/ct2/show/record/NCT02040272Accessed October 8, 2018
   Google Scholar
• RicciardiSCardilloGZirafaCCSurgery for malignant pleural mesothelioma: an international guidelines reviewJ Thorac Dis201810Suppl 2S285S29229507797
   PubMed Web of Science ®Google Scholar
• RintoulRCRitchieAJEdwardsJGEfficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trialLancet201438499481118112724942631
   PubMed Web of Science ®Google Scholar
• WoolhouseIBishopLDarlisonLBritish Thoracic Society guideline for the investigation and management of malignant pleural mesotheliomaThorax201873Suppl 1i1i3029444986
   PubMed Web of Science ®Google Scholar
• VogelzangNJRusthovenJJSymanowskiJPhase III study of peme-trexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotheliomaJ Clin Oncol200321142636264412860938
   PubMed Web of Science ®Google Scholar
• GrallaRJHollenPJAmLLiepaAMImproving quality of life in patients with malignant pleural mesothelioma: Results of the randomized pemetrexed and cisplatin vs. cisplatin trial using the LCSS-meso instrumentProc Am Soc Clin Oncol200322 abstr 2496
   Web of Science ®Google Scholar
• ZalcmanGMazieresJMargeryJBevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma Avastin cisplatin pemetrexed study (MAPs): a randomised, controlled, open-label, phase 3 trialLancet2016387100261405141426719230
   PubMed Web of Science ®Google Scholar
• WesteelVEberstGAnotaAImpact on health-related quality of life of the addition of bevacizumab to cisplatin-pemetrexed in malignant pleural mesothelioma in the maps phase III trialJ Clin Oncol201836Suppl 1585058505
   Web of Science ®Google Scholar
• CinauseroMRihawiKSperandiFMelottiBArdizzoniAChemotherapy treatment in malignant pleural mesothelioma: a difficult historyJ Thorac Dis201810Suppl 2S304S31029507800
   PubMed Web of Science ®Google Scholar
• SantoroAO’BrienMEStahelRAPemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International expanded access programJ Thorac Oncol20083775676318594322
   PubMed Web of Science ®Google Scholar
• MuersMFStephensRJFisherPActive symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialLancet200837196251685169418486741
   PubMed Web of Science ®Google Scholar
• BibbyACMaskellNACurrent treatments and trials in malignant pleural mesotheliomaClin Respir J20181272161216930129116
   PubMed Web of Science ®Google Scholar
• AlleyEWLopezJSantoroAClinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1B trialLancet Oncol201718562363028291584
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]European Thoracic Oncology Platform. Identifier: NCT02991482. PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma (PROMISE-meso) Available from: https://clinicaltrials.gov/ct2/show/NCT02991482Accessed October 8, 2018
   Google Scholar
• ZalcmanGMazieresJGreillierLSecond or 3rd line nivolumab versus nivolumab plus ipilimumab in malignant pleural mesothelioma patients: updated results of the IFCT-1501 MAPS2 randomized phase 2 trial2017 ESMO Congress Abstract LBA58_PR; September 10, 2017
   Google Scholar